αB-crystallin, a small heat shock protein, modulates NF-κB activity in a phosphorylation-dependent manner and protects muscle myoblasts from TNF-α induced cytotoxicity  by Adhikari, Amit S. et al.
Biochimica et Biophysica Acta 1813 (2011) 1532–1542
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrαB-crystallin, a small heat shock protein, modulates NF-κB activity in a
phosphorylation-dependent manner and protects muscle myoblasts from TNF-α
induced cytotoxicity
Amit S. Adhikari, Bhairab N. Singh, K. Sridhar Rao, Ch Mohan Rao ⁎
Centre for Cellular and Molecular Biology, Council of Scientiﬁc and Industrial Research, Hyderabad 500 007, India⁎ Corresponding author. Fax: +91 40 2716 0591.
E-mail address: mohan@ccmb.res.in (C.M. Rao).
0167-4889/$ – see front matter © 2011 Elsevier B.V. A
doi:10.1016/j.bbamcr.2011.04.009a b s t r a c ta r t i c l e i n f oArticle history:
Received 20 September 2010
Received in revised form 27 April 2011
Accepted 27 April 2011
Available online 25 May 2011
Keywords:
HSP
αB-crystallin
TNF-α
NF-κB
Apoptosis
DifferentiationαB-crystallin, a member of the small heat shock protein family, has been implicated in various biological
functions including response to heat shock, differentiation and apoptosis, the mechanisms of which have not
been well understood. Myoblasts, the precursor cells in muscle regeneration, when subjected to growth factor
deprivation differentiate to form myotubes or undergo apoptosis. During differentiation, myoblasts express
elevated levels of αB-crystallin as well as TNF-α but the connecting link between these proteins in cell
signaling is not clearly understood. We have therefore investigated the role of αB-crystallin in TNF-α induced
regulation of NF-κB.
We demonstrate that in response to TNF-α treatment, αB-crystallin associates with IKKβ and activate its
kinase activity, facilitating the degradation of phosphorylated I-kBα, a prime step in NF-κB activation.
Reducing the level of αB-crystallin using the RNAi approach reduces the translocation of p65, further
conﬁrming the role of αB-crystallin in NF-κB activation. Our study shows that the ability of αB-crystallin to
activate NF-κB depends on its phosphorylation status. The present study shows that αB-crystallin-dependent
NF-κB activation protects myoblasts from TNF-α induced cytoxicity by enhancing the expression of the anti-
apoptotic protein, Bcl 2. Thus, our study identiﬁes yet another mechanism by which αB-crystallin exerts its
anti-apoptotic activity.ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Maintenance and survival of cells depends on their ability to cope
with the stress conditions. One of the major consequences of stress
is the compromised protein function possibly due to its altered
conformation. Under conditions of stress, a family of proteins called
the heat shock proteins (HSPs), gets up-regulated or activated, which
confers protection to the cells [1–3]. HSPs play a crucial role in
maintaining protein homeostasis and are involved in many cellular
processes [1]. Small heat shock proteins (sHSPs) function asmolecular
chaperones in preventing the aggregation of non-native state(s) of
proteins and assist in their refolding [4–6]. These proteins have
subunit molecular mass ranging between 12 and 43 kDa and share a
conserved domain in their C-terminal region spanning approximately
80–100 amino acid residues called the “alpha-crystallin domain” [7,8].
αB-crystallin, a member of small heat shock protein family, is
abundantly expressed in eye lens and inmany non-lenticular cells such
as brain, heart, skeletal muscle, kidney, etc.[9,10]. It gets up-regulated
upon stress and certain pathological conditions such as oxidative stress,heat stress, Alexander's disease, Parkinson's disease, etc.[11,12]. It has a
monomeric mass of 20 kDa and exists as a large oligomer of approx-
imately 600 kDa. Functionally, αB-crystallin acts as a molecular
chaperone and prevents the stress-induced aggregation of target
proteins [13,14]. Studies from our laboratory have shown that α-
crystallin undergoes structural alteration and displays enhanced
chaperone activity at higher temperature [14–16]. In addition to its
chaperone functions, αB-crystallin plays an important role in many
cellular events such as proliferation, differentiation and apoptosis
[17–19].
We have shown that in heat-stressed myoblasts, αB-crystallin
associates with F-actin in the cytoplasm and also translocates into the
nucleus, where it colocalizes with the lamin A/C network [20,21]. The
association of αB-crystallin with cytoskeletal and nucleoskeletal
proteins is suggestive of its cytoprotective function under conditions
of stress. A point mutation (R120G) in αB-crystallin results in
pathologies such as desmin related myopathy [DRM] in muscle cells,
demonstrating its function in muscle maintenance [22,23]. Studies
from our laboratory as well as those from other laboratories indicate
that the mutant protein has compromised chaperone activity, which
could be the molecular basis of the observed pathology [24–26].
Moreover, the knockout mice for αB-crystallin die prematurely
with extensive muscle wastage, corroborating the importance of
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differentiation, the level of αB-crystallin is elevated 10-fold, and it
plays a critical role in preventing apoptotic cell death induced during
the differentiation process [18,28]. In addition, αB-crystallin has been
shown to prevent cell death induced upon oxidative stress as well as
staurosporin and doxorubicin treatment [19,29–31]. Various studies
show that αB-crystallin interacts directly with Bax and Bcl Xs and
prevents apoptosis by inhibiting their translocation intomitochondria
[30]. Further, αB-crystallin has been found to inhibit maturation/
activation of executor caspases such as caspase-3 and -8 in response
to TNF-α treatment, thus preventing cellular responses to death
signals [31].
TNF-α is an inﬂammatory cytokine produced by immune cells and
muscle cells during development and strenuous exercise or injury
[32–34]. Besides the known role as an inducer of inﬂammation,
cachexia and cytotoxicity, TNF-α is essential for muscle tissue
homeostasis as injecting antibodies or knocking out TNF-α or its
receptor, results in mice with lower muscle mass [32–34]. TNF-α acts
as a mitogen in skeletal muscle [33,35] and is involved in modulating
the activity of NF-κB, a ubiquitous transcription factor that in turn
regulates the expression of many genes in a condition-dependent
manner [36]. NF-κB has been shown to be associated in many cellular
processes such as growth, differentiation, inﬂammation, apoptosis
and stress response [37]. However, an aberrantly active NF-κB could
lead to chronic or excessive inﬂammation associated with diseases
such as rheumatoid arthritis, asthma, etc.[37–40]. Therefore, NF-κB,
being a central transcription factor needs to be modulated precisely to
perform its function.
Expression of αB-crystallin and TNF-α is reported to increase in
response to stress and differentiation [18,29,33]; however, prolonged
exposure to TNF-α has cytotoxic effects. The relation between the
elevated expression of αB-crystallin and TNF-α, if any, is not
understood. We have investigated the effect of αB-crystallin, if any,
on TNF-α-induced modulation of NF-κB activation as well as cell
survival in C2C12 mouse myoblasts. Our study shows that αB-
crystallin promotes NF-κB activation, in a phosphorylation-dependent
manner, and protects myoblasts against TNF-α induced cytotoxicity.
This study also brings out another pathway by which αB-crystallin
exerts its anti-apoptotic effect.Fig. 1. Luciferase reporter gene assay for NF-κB. C2C12, CRYAB-C2C12 and R120G-
C2C12 cells were transiently transfected with NF-κB reporter plasmid as described in
Section 2. 24 hpost-transfection, the cells were treated with TNF-α [20 ng/mL] for 6 h
and the luciferase activity was measured. Transfection efﬁciency was normalized using
β-galactosidase expression assay. The bar diagram represents fold change in luciferase
activity of TNF-α-treated C2C12 cells and of untreated or TNF-α-treated CRYAB-C2C12
or R120G-C2C12 cells over that observed in untreated C2C12 cells.2. Experimental
2.1. Cell culture and reagents
DMEM, fetal calf serum (FCS), anti-FLAG antibody (M2 clone), and
cycloheximide were purchased from Sigma Chemical Company, USA.
Kinase inhibitors, SB202190 (p38-MAP kinase) and PD098059 (p44-
MAP kinase), and TNF-α were obtained from Calbiochem, EMD
Biosciences Inc. Germany. Propidium iodide (PI), Alexa-488- and Cy3-
conjugated secondary antibodies were obtained from Molecular
Probes, Invitrogen Corp.,OR, USA. Anti-actin mouse monoclonal
antibodies were purchased from Chemicon International Inc., USA.
Rabbit anti-IKKα/β, mouse anti-IKKβ, rabbit anti-β-tubulin, rabbit
anti-IκBα, mouse anti-phospho-IκBα and rabbit anti-p65 antibodies
were purchased from Santa Cruz, USA. Mouse monoclonal anti-αB-
crystallin, rabbit polyclonal anti-αB-crystallin and rabbit polyclonal
Ser-59-αB-crystallin antibodies were purchased from Stressgen,
Victoria, Canada. Mouse monoclonal anti-Bcl 2 antibodies were
purchased from BD Biosciences, USA. Monoclonal anti-HA antibodies
and protease inhibitor cocktail were procured from Roche Applied
Sciences, USA. Lipofectamine-2000 was procured from Invitrogen,
USA. HRPO-conjugated secondary antibodies and enhanced chemilu-
minescence (ECL) Western blot detection kit were obtained from
Amersham Biosciences, USA. Vectashield mounting medium contain-
ing DAPI was purchased from Vector Laboratories, USA.Mouse skeletal myoblast cell line C2C12 was maintained at sub-
conﬂuent densities (60–70%) in DMEM supplemented with 20% fetal
calf serum at 37 °C in a humidiﬁed atmosphere containing 5% CO2.
2.2. Plasmids and construction of FLAG-tagged cDNAs
The full-length cDNAs of αB-crystallin and R120G-αB-crystallin
were PCR-ampliﬁed using the following primers: forward primer-5′-
GGCCGAATTCATGGACATCGCCATCCACCAC-3′ and reverse primer- 5′-
GCCCTCGAGCTATTTCTTGGGGGCTGCGG-3′. The PCR products were
digested with EcoR1 and Xho1 restriction enzyme and ligated into a
modiﬁed pCDNA3 vector in which the FLAG epitope was inserted
upstream of the multiple cloning site and conﬁrmed by automated
DNA sequencing. pEGFP vector was procured from Clontech labora-
tories Inc., USA. The plasmid pCDNA 3.1 HA-3A αB-crystallin
(hemagglutin tagged αB-crystallin, where serine residues at 19, 45
and 59 position were replaced with alanine, thus mimicking a non-
phosphorylable mutant form), which was provided by Dr. C.C.
Glembotski, SDSU Heart Institute and Department of Biology, San
Diego, USA. The pSUPER vector and pRNAi-αB-crystallin were
provided by Dr. V. Cryns, Departments of Medicine and Cell and
Molecular Biology, Northwestern University, Chicago, USA.
2.3. Stable and transient transfections
For stable transfections, C2C12 cells grown in six-well plate were
transfected with 1μg of pcDNA3-N FLAG plasmids or control vector
pEGFP-N1 using Lipofectamine 2000 reagent following the manufac-
turer's protocol. Stably transfected cells were selected using G418
(geneticin) and single cell clones expressing approximately 2-fold
higher levels of αB-crystallin or R120G-αB-crystallin (Western blot
analysis done using FLAG- speciﬁc antibodies) were selected,
expanded and used for our study.
ForNF-κB reporter geneassay experiments, 400 ngofNF-κB reporter
plasmid, HIV LTR-luciferase (containing three NF-κB binding sites) [38],
alongwith 75 ngof pCMVβ-gal reporter plasmidwere transfectedusing
Lipofectamine 2000. The cells, 24 h post-transfection,were treatedwith
TNF-α (20 ng/ml) for 6 h. Reporter gene activity was determined with
the luciferase assay kit [Promega, Madison, USA]. β-Galactosidase
activity was used to normalize the transfection efﬁciency. In some
experiments, the cells were treated with either DMSO (vehicle) or
20 μM SB202190 (p38-MAPK inhibitor) for 6 h and subsequently
treated with TNF-α.
For investigating the effect of silencing of αB-crystallin on nuclear
translocation of NF-κB, C2C12, CRYAB-C2C12 and R120G-C2C12 cells
were co-transfected with pRNAi-αB plasmid and pGFP-V-RS vector
(Origene Technologies Inc., USA, which contained puromycin resistance
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of puromycin for 5 days and subsequently with 0.5 μg/mL for another
3 days. The total cell lysate and the isolatednuclei fromknockout pool of
cells were used for Western blot analysis.
2.4. Isolation of nuclei
For isolation of nuclei, 3–4 million cells were harvested using the
non-enzymatic cell dissociation solution. After washing twice with PBS,
cells were resuspended in low-salt buffer (10 mM HEPES, pH 7.4,
10 mM KCl, 0.5 mM EDTA, 0.1 mM EGTA, 0.1 mM DTT, 2 mM phenyl
methyl sulfonyl ﬂuoride (PMSF), and the protease inhibitor cocktail
(Roche). After 10 min on ice, cells were passed through 20 gauge needle
4–5 times to dislodge the clumps and then ruptured by passing through
a 26 gauge needle. The enrichment of nuclei was achieved by sedi-
mentation of crude nuclear pellet through 300 mM-sucrose cushions at
400×g. The isolated nuclei were lysed by freeze–thaw method.
2.5. Immunoﬂuorescence microscopy
C2C12 and CRYAB-C2C12 cells were grown on cover slips and
transfected with HA-3A αB-crystallin mutant using LipofectamineFig. 2. Nuclear translocation of NF-κB p65 protein. A. Western blot showing the levels of p65
CRYAB-C2C12 and R120G-C2C12 cells. B. Bar diagram representing fold changes in the nuc
intensities]. C. Confocal images of cells showing the translocation of p65 in untreated [left sid
determined with a paired Student's t test with *pb0.02 and ***pb0.002, respectively.reagent according to the manufacturer's protocol. For the RNAi
experiments, cells were co-transfected with pRNAi-αB plasmid and
pEGFP vector. Cells were then treated with TNF-α for indicated time
points, washed twice with PBS and ﬁxed with 3.7% formaldehyde. The
ﬁxed cells were permeabilized with 0.05% Triton X-100 for 8 min.
After blocking with 2% BSA, cells were incubated overnight with anti-
HA monoclonal antibodies and anti-p65 rabbit polyclonal antibodies.
The cover slips were then washed with PBS and further incubated
with anti-mouse Ig-Alexa-488 or anti-rabbit Ig-Cy3-tagged secondary
antibodies. The cells weremounted in Vectashieldmedium containing
DAPI. Confocal laser scanning microscopy was performed on a Carl
Zeiss inverted microscope. Image analysis was done using LSM
510meta software (Version 5).
2.6. SDS-PAGE and Western blot analysis
C2C12, CRYAB-C2C12 and R120G-C2C12 cells were treated with
TNF-α and harvested at indicated time points. Cells were lysed in ice-
cold lysis buffer containing 20 mM HEPES, pH 7.5 containing 50 mM
NaCl, 1 mM EDTA, 30 mM NaF, 2 mM Na3VO4, 0.5 mM PMSF, 0.1%
Nonidet-P40, and protease inhibitor cocktail, sonicated and centri-
fuged at 20,800×g for 10 min at 4 °C. Protein estimations were doneprotein [top panel] and lamin A [bottom panel] in nuclear lysates isolated from C2C12,
lear levels of p65 [densitometeric intensities of p65 normalized with those for lamin A
e panel] and TNF-α treated cells [right side panel]. Bar: 10 μmStatistical signiﬁcance was
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SDS-polyacrylamide gels and transferred to nitrocellulose membrane
using semi-dry transfer apparatus (Millipore, USA). The membrane
was blocked with 10% milk protein and sequentially incubated with
appropriate primary antibodies and HRPO-conjugated secondary
antibodies and visualized using Amersham-Pharmacia ECL detection
kit.
2.7. Inhibitor kappa kinase (IKK) assay
Cells were treated with 20 ng/ml of TNF-α for 10 min and then cells
were lysed using buffer containing 50 mM Tris–HCl buffer (pH 7.4)
containing 50 mMNaCl, 5 mM EDTA, 50 mMNaF, 1 mM PMSF, 0.2 mM
Na3VO4, 0.2% NP40, 10% glycerol (IP buffer). In some experiments, the
cells were treated with 20 μM SB202190, for 6 h. Total cell lysates
(500 μg of protein)were incubatedwith anti-IKKα/β antibody and then
immunoprecipitated using Protein-G beads. The beads were washedFig. 3. Effect of RNAi-mediated silencing of αB-crystallin on nuclear translocation of NF-
expression level of αB-crystallin. A signiﬁcant reduction in the level of αB-crystallin is obser
small heat shock protein, Hsp25. Western blot of GAPDH showing loading control. B. West
nuclear lysates isolated from C2C12 and CRYAB-C2C12 cells. C. Confocal images showing th
TNF-α-treated C2C12 and CRYAB-C2C12 cells.twice and incubated in kinase reaction buffer (20 mM HEPES, pH 7.5
containing 5 mM MgCl2, 25 mM β-glycerophosphate, 1 mM sodium
orthovanadate, 100 mMNaF, 1 mMdithiothreitol) 10 μMdisodiumATP
and 0.5 μCi of [γ-32P] ATP and 100 ng of recombinant IκBα and
incubated for 30 min at 30 °C. The reaction was terminated using
Laemmli sample buffer and the proteins were resolved by 15% SDS-
PAGE. Radioactivity was detected by phospho-imaging and quantitated
by densitometry using GeneTool software.
2.8. Immunoprecipitation and Western blot analyses
C2C12, CRYAB-C2C12 and R120G-C2C12 cells were treated with or
without TNF-α (20 ng/ml) for 30 min. The cells were lysed by
sonication with two pulses of 10 s duration, in IP buffer. The total
cell extracts (750 μg to 1 mg of protein) were incubated with 1 μg of
anti-IKKα/β antibody or αB-crystallin antibodies overnight at 4 °C.
Subsequently, protein-Gmagnetic beads were added to these samplesκB p65 protein. A. Western blot showing the effect of pRNAi-αB transfection on the
ved in C2C12 cells, while there is no effect on the expression of another closely related
ern blots showing the levels of p65 protein [top panel] and Lamin A [bottom panel] in
e effect of RNAi-mediated silencing of αB-crystallin on nuclear translocation of p65 in
Fig. 4. αB-Crystallin enhances phosphorylation and subsequent degradation of IκBα.
A. Upper panel, Western blots showing the levels of phospho-IκBα and β-tubulin in
C2C12, CRYAB-C2C12 and R120G-C2C12 cells. Lower panel, bar diagram showing the
ratio of densitometric intensities of phospho-IκBα and β-tubulin. B. Upper panel,
Western blot showing the levels of total IκBα in C2C12, CRYAB-C2C12 and R120G-
C2C12 cells. Lower panel, bar diagram shows the ratio of densitometric intensities of
IκBα and β-tubulin [bottom panel]. The mean intensity±SE represents an average of
three replicate samples. Statistical signiﬁcance was determined with a paired Student'st
test, with *pb0.02, **pb0.005 and ***pb0.002, respectively.
1536 A.S. Adhikari et al. / Biochimica et Biophysica Acta 1813 (2011) 1532–1542and they were incubated further for 4 h. The magnetic bead complex
was retrieved using a magnetic separator kit (Bangs Laboratories Inc.,
USA). The immunoprecipitated complex was washed thrice with ice-
cold IP buffer and suspended in Laemmli buffer. The samples were
heated in a boiling water bath for 5 min and subjected to SDS-PAGE.
The proteins were transferred onto a nitrocellulose paper (Hybond C,
Amersham Biosciences, Sweden), probed using speciﬁc antibodies as
indicated and then visualized using ECL system.
2.9. Induction of apoptosis
Apoptosis was induced in normal C2C12 cells, CRYAB-C2C12 and
R120G-C2C12 cells by treatment with 100 ng/ml TNF-α for 18 h. In
some experiments, cells were treated with 20 μM SB202190 or the
vehicle-DMSO alone for 6 h prior to TNF-α treatment. At the end of
the treatment, the cells were ﬁxed in 80% methanol, stained with
propidium iodide and analyzed by using Fluorescence Activated Cell
Sorter (FACS-Caliber, Becton and Dickinson, USA). The percent of sub-
G1 population that represents apoptotic cells was estimated. The
values represent an average of three independent experiments and
are expressed as percentage.
3. Results
3.1. αB-crystallin promotes DNA-binding and transcriptional activity of
NF-κB
Serum starvation induces elevated levels ofαB-crystallin as well as
TNF-α C2C12 myoblasts [18,33]. However, prolonged exposure of
cells to this cytokine induces cell death [41]. The relation between
the elevated expression of αB-crystallin and TNF-α, if any, is not
understood. Since TNF-α is known to modulate NF-κB activity, we
have investigated NF-κB activation upon treating normal, CRYAB-
C2C12 and R120G-C2C12 cells with TNF-α, using luciferase reporter
assay (Fig. 1). In the absence of TNF-α, CRYAB-C2C12 cells showed
~1.5-fold higher luciferase activity compared to C2C12 cells. Upon
TNF-α treatment for 6 h, C2C12 cells showed 4- to 5-fold enhanced
luciferase activity compared to untreated cells (Fig. 1). Interestingly,
TNF-α treatment of CRYAB-C2C12 cells resulted in 10- to 11-fold
increase in luciferase activity with respect to untreated C2C12 cells
and about 6- to 7-fold increase with respect to untreated CRYAB-
C2C12 cells (Fig. 1). The cells expressing the functionally compro-
mised R120G mutant of αB-crystallin exhibit luciferase activity
comparable to that of the respective controls of C2C12 cells either in
the absence or in the presence of TNFα (Fig. 1). Thus, the luciferase
reporter assay clearly indicates that αB-crystallin but not R120GαB-
crystallin promotes the functional activation of NF-κB upon treating
the myoblasts with TNFα.
Nuclear translocation is the prime step in the activation of NF-κB
[37–40]. We further conﬁrmed the activation of NF-κB by Western blot
analysis of p65 using nuclear lysates. Upon treatment with TNF-α, the
nuclear levels of p65 in C2C12 cells is increased to 1.5-fold compared to
untreated cells (Fig. 2A). It is important to note that, in untreated
CRYAB-C2C12 cells, the level of nuclear p65 was comparable to that in
TNF-α treated C2C12 cells, which further increased by 2.5-fold upon
TNF-α treatment as compared to parental C2C12 cells. Interestingly, we
ﬁnd that the nuclear level of p65 in R120G-C2C12 cells (untreated as
well as TNF-α treated) is found to be comparable to C2C12 cells treated
with TNF-α. In addition, thenuclear p65 levels in R120G-C2C12 cells did
not change signiﬁcantly before and after TNF-α treatment (Fig. 2A). To
further validate our data, we performed immunostaining of p65 in
C2C12, CRYAB-C2C12 and R120G-C2C12 cells before and after TNF-α
treatment. In the absence of TNF-α, p65 staining showed mostly
cytoplasmic localization,while upon treatment, p65 gets translocated to
the nucleus (Fig. 2B). Upon TNF-α treatment, the staining for p65 in
C2C12 cells was seen both in the cytoplasm and the nucleus, whereas inCRYAB-C2C12 cells, a signiﬁcant fraction of p65was in the nucleuswith
very little or no staining in the cytoplasm (Fig. 2B). Interestingly, we
observe that the stainingpattern is verymuchdifferent inR120G-C2C12
cells as compared to both parental C2C12 and CRYAB-C2C12 cells. In
these cells, the staining pattern of p65 is diffuse, while in R120G-C2C12
cells, nuclear p65 has speckled appearance (Fig. 2B). Moreover, the
nuclear accumulation of p65 in R120G-C2C12 cells did not change (with
or without TNF-α treatment), thus supporting our Western blot data
(Fig. 2A). Our investigations using gel shift assay show an enhanced
DNA-binding ability of NF-κB in nuclear extracts from CRYAB-C2C12
cells compared to parental C2C12 cells, suggesting that αB-crystallin
increases the promoter activity of NF-κB (data not shown).
Taken together, our results suggest thatαB-crystallin enhances the
nuclear translocation and the transcriptional activity of NF-κB upon
TNF-α treatment.
3.2. RNAi-mediated decrease in αB-crystallin level reduces nuclear
translocation of NF-κB
C2C12 and CRYAB-C2C12 cells were transiently transfected either
with pSUPER vector (control) or with pRNAi for αB-crystallin, using
Lipofectamine. In our experimental conditions, we observed a transfec-
tion efﬁciency of approximately 25-30%. We observed a large reduction
in the level of αB-crystallin with the pRNAi-αB plasmid but not with
pSUPER vector, whereas the expression of another small heat shock
protein, HSP25, was unaffected by the transfection of both the plasmids
(Fig. 3A). Densitometric analysis using Image J (NIH, USA) software, we
achieved a knockdown ofαB-crystallin expression by 62%. After 24 h of
transfection, C2C12 and CRYAB-C2C12 cells were treated with TNF-α
(20 ng/ml) for 6 h and Western blot analysis was performed for p65 in
the nuclear fractions. Our Western blot data clearly show that upon
TNF-α treatment there is marked decrease in the level of nuclear p65 in
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with pSUPER vector alone (Fig. 3B).
3.2.1. Immunolocalization experiments were also for p65 in normal and
RNAi- mediated αB-crystallin knocked down cells upon TNF-α treatment
Our confocal data show that the cells transfected with pSUPER
vector display nuclear staining of p65 in C2C12 as well as in CRYAB-
C2C12 cells (Fig. 3C). It is important to mention here that, in CRYAB-
C2C12 cells, the staining of p65 was muchmore intense in the nucleus
than in the cytoplasm, whereas in C2C12 cells both cytoplasmic and
nuclear staining was of similar intensity. The nuclear to cytoplasmic
ratio of the mean intensities of p65 in untransfected cells and in cells
transfected with pSUPER vector alone was 1.45, suggesting that
transfection per se does not alter the localization of p65. Importantly,
we ﬁnd that the nuclear-cytoplasmic ratio of the mean intensities of
p65 is reduced to 0.74 in the cells transfected with pRNAi-αB
construct, indicating that reducing the levels of αB-crystallin
signiﬁcantly reduces the nuclear translocation of p65. Similarly, in
CRYAB-C2C12 cells, the nuclear–cytoplasmic ratio of the mean
intensities of p65 was found to be 1.74 in pSUPER vector alone
transfected cells, which reduces to 0.72 in cells transfected with the
pRNAi-αB construct. In support of the Western blot data, we found
that upon knocking down the levels of αB-crystallin by pRNAi, the
nuclear translocation of p65 decreased dramatically and it was
completely localized to the cytoplasm (Fig. 3C). Taken together, our
Western blot and confocal analysis results show that reduction of αB-Fig. 5. αB-Crystallin enhances the kinase activity of IKK complex upon treatment with
TNF-α. A. IKK complex was immunoprecipitated from cell lysates of C2C12, CRYAB-
C2C12 and R120G-C2C12 cells using antibody speciﬁc for IKK-α/β. The kinase activity of
the immunoprecipitated complex was measured as described in Section 2. The fold
change in the kinase activity of TNF-α-treated C2C12 cells, and of untreated or TNF-α-
treated CRYAB-C2C12 or R120G-C2C12 cells compared to that of untreated C2C12 cells
is represented in the bar diagram [bottom panel]. B. Lysates from C2C12 and CRYAB-
C2C12 cells were immunoprecipitated using antibodies speciﬁc for αB-crystallin. The
kinase activity in the immunoprecipitated complex was measured. The fold change in
the kinase activity of TNF-α-treated C2C12 cells, and of untreated or TNF-α-treated
CRYAB-C2C12 or R120G-C2C12 cells compared to that of untreated C2C12 cells is
represented in the bar diagram [bottom panel]. The mean intensity±SE represents an
average of three replicate samples. Statistical signiﬁcance was determined with a paired
Student'st test, with *pb0.02, **pb0.005 and ***pb0.002 respectively.crystallin levels leads to decreased nuclear translocation of NF-κB, and
therefore its activity. These observations conﬁrm the speciﬁc role of
αB-crystallin in modulating nuclear translocation of NF-κB, thereby
regulating its TNF-α-induced activation.
3.3. αB-crystallin enhances phosphorylation and subsequent
degradation of IκBα
In order to understand the mechanism of NF-κB activation by αB-
crystallin, we have analyzed the phosphorylation status and the levels
of the Inhibitor κB-α (I-κBα). I-κBα is bound to the p65–p50 complex
of NF-κB, keeping it in an inactive form by masking the nuclear
translocation signal [40], thereby causing its cytoplasmic retention
and blocking both its DNA-binding and transactivation abilities.
Phosphorylation of I-κBα at serine residues 32 and 36 releases it
from the complex, followed by its subsequent degradation by the 26S
proteosome [42,43]. Using Western blot analysis, we have investigat-
ed the levels and phosphorylation status of I-κBα in C2C12, CRYAB-
C2C12 and R120G-C2C12 cells upon TNF-α treatment. The levels of
phosphorylated I-κBα in C2C12 cells treated with TNF-α increased by
2.2-fold as compared to untreated cells (Fig. 4A). Importantly, the
levels of phosphorylated I-κBα in untreated CRYAB-C2C12 cells were
comparable to those of TNF-α treated C2C12 cells. Moreover, the
phosphorylation of I-κBα in CRYAB-C2C12 cells increased signiﬁcant-
ly (3.7-fold) upon TNF-α treatment. Interestingly, the phosphoryla-
tion level of I-κBα in R120G-C2C12 cells was slightly less than that in
the control C2C12 cells, and did not change after treatment with
TNF-α (Fig. 4A).
The phosphorylation of I-κBα renders it susceptible to degradation
[43]. In order to monitor the degradation of I-κBα, we have carried outFig. 6. Changes in the expression levels of αB-crystallin and the status of its
phosphorylation on Ser-59 residue upon treatment with TNF-α. A. Western blots
showing the levels of αB-crystallin and β-tubulin in the untreated and TNF-α-treated
C2C12, CRYAB-C2C12 and R120G-C2C12 cells. Fold change in the levels of αB-crystallin
normalized to β-tubulin levels is represented in the bar diagram [bottom panel].
B. Western blots showing the relative changes in Ser-59 phosphorylated αB-crystallin.
Fold change in the Ser-59 phosphorylation ofαB-crystallin in C2C12, CRYAB-C2C12 and
R120G-C2C12 cells is represented in the bar diagram [bottom panel]. The mean
intensity±SE represents an average of three replicate samples. Statistical signiﬁcance
was determined with a paired Student'st test, with ##pb0.05, *pb0.02, and **pb0.005,
respectively.
Fig. 7. Phosphorylation of αB-crystallin is essential for its ability to enhance nuclear
translocation of NF-κB-p65-protein. A. C2C12, CRYAB-C2C12 and R120G-C2C12 cells
were transiently transfected with NF-κB reporter plasmid as described in Section 2. The
bar diagram represents the fold changes in luciferase activity in cells treated with
TNF-α, in the presence or the absence of p38-MAPKinase inhibitor, SB202190.
B. Confocal images showing the nuclear translocation of NF-κB-p65-protein in C2C12
cells expressing a non-phosphorylatable mimic ofαB-crystallin, the HA-3A-αB-crystallin,
in the presence or the absence of TNF-α.
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I-κBα were less in case of CRYAB-C2C12 cells than in C2C12 and
R120G-C2C12 cells (Fig. 4B). Upon TNF-α treatment, there was
further decrease in I-κBα levels in CRYAB-C2C12 cells, which was
even less than that in normal C2C12 cells treated with TNF-α. There
was no signiﬁcant change in I-κBα levels in R120G-C2C12 cells after
TNF-α treatment (Fig. 4B). This suggests that αB-crystallin enhances
the degradation of I-κBα, a key regulatory step involved in the
activation and nuclear translocation of NF κB.Fig. 8. Effect of the inhibition of Ser-59 phosphorylation of αB-crystallin on its association w
TNF-α-treated C2C12 and CRYAB-C2C12 cells were immunoprecipitated with antibodies sp
of IKK-β and αB-crystallin by Western blotting. The bar diagram show no signiﬁcant
B. Immunoprecipitates obtained as above, were analyzed for their kinase activity. The fold
signiﬁcance was determined with a paired Student'st test, with **pb0.005.3.4. αB-crystallin enhances the kinase activity of IKK complex
To elucidate the mechanism by which αB-crystallin enhances the
phosphorylation of I-κBα and its subsequent degradation, we investi-
gated the kinases that are responsible for the phosphorylation of I-κBα.
IKKβ, the predominant kinase of the IKK complex, is involved in
phosphorylation of I-κBα [42]. The IKK complex was immunoprecipi-
tated from the lysates of control or TNF-α-treated C2C12, CRYAB-C2C12
and R120G-C2C12 cells. Under normal condition, the kinase activity of
immune complex of C2C12 and R120G-C2C12 cells was comparable,
whereas that of CRYAB-C2C12 cells was ~2-fold higher as compared to
parental cells (Fig. 5A). Upon TNF-α treatment, normal C2C12 cells
showed ~2-fold increased kinase activity, while CRYAB-C2C12 exhibited
~4-fold increase in kinase activity to that of untreated parental cells.
Surprisingly, R120G-C2C12 showedadecrease in thekinase activityupon
TNF-α treatment compared to untreated C2C12 or CRYAB-C2C12 cells
(Fig. 5A). These results suggest that over-expression of αB-crystallin
results in a speciﬁc increase in the kinase activity of the IKK complex.
3.5. αB-crystallin interacts with the IKK complex
The enhancement in the kinase activity in CRYAB-C2C12 cells
prompted us to investigate the possible interaction of αB-crystallin
with the IKK complex. Normal C2C12, CRYAB-C2C12 and R120G-C2C12
cells were treated with TNF-α [20 ng/ml] for 30 min. Immunoprecipi-
tation was performed using antibodies speciﬁc to αB-crystallin and
Western blotwas performed using IKK antibodies. The interaction of IKK
withαB-crystallin thatwas faintly detectable in untreated C2C12 cells is
evident in TNF-α-treated C2C12 cells (Fig. 5B). The interaction of IKK
withαB-crystallinwas signiﬁcant in CRYAB-C2C12 cells in theuntreated
condition (Fig. 5B), which further increases upon treatmentwith TNF-α.
The interaction of IKK complexwithαB-crystallinwas further conﬁrmed
by reverse immunoprecipitation using IKKα/β-speciﬁc antibodies (data
not shown). Thus, our study suggests that association of αB-crystallin
with the IKK complex results in increase in its kinase activity.
3.6. Effects of TNF-α on the expression and phosphorylation of
αB-crystallin
In order to study the effect of TNF-α on the expression of αB-
crystallin, C2C12, CRYAB-C2C12 and R120G-C2C12 cells were treatedith IKK complex and the activation of kinase activity. A. Cell lysates from untreated and
eciﬁc for αB-crystallin. The immunoprecipitated complex was analyzed for the levels
changes in ratio of the densitometric intensities of IKK- β/αB-crystallin (pN0.6).
changes in the kinase activity are shown in the bar diagram [bottom panel]. Statistical
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αB-crystallin. Upon treatment with TNF-α in C2C12 cells, there is an
increase in the αB-crystallin level. We observed no signiﬁcant change
inαB-crystallin levels upon TNF-α treatment in CRYAB-C2C12 cells or
in R120G-C2C12 cells [Fig. 6A]. It is possible that the increased
expression of αB-crystallin in CRYAB-C2C12 cells is sufﬁcient to
counter cytotoxic effects of TNF-α.
It is well-known that TNF-α treatment activates p38-MAP kinase
[44]; it is also known that p38-MAP kinase is involved in the phos-
phorylation of αB-crystallin at Ser-59 residue under stress conditions
[45,46]. Phosphorylation of αB-crystallin plays an important role
in modulating its activity, localization, interaction with other
proteins and its cellular functions [47–49]. Western blot analysis
using Ser-59 phospho-speciﬁc antibodies shows that TNF-α treat-
ment increases phosphorylation of αB-crystallin in C2C12 cells
(Fig. 6B). In untreated CRYAB-C2C12 cells, we observed an enhanced
phosphorylation at the Ser-59 residue compared to untreated C2C12
cells, which further increased upon TNF-α treatment (Fig. 6B).
Compared to the normal C2C12 cells, untreated R120G-C2C12 cellsFig. 9. Protective effect of αB-crystallin-induced NF-κB activity against TNF-α-induced
cytotoxicity. A. Bar diagram representing percent cytoxicity in untreated and TNF-α
treated C2C12, CRYAB-C2C12 and R120G-C2C12 cells. B. Bar diagram representing
percent cytotoxicity in untreated and TNF-α treated C2C12, CRYAB-C2C12 and R120G-
C2C12 cells in the presence or the absence of p38-MAPK inhibitor, SB202190. The
mean±SE was calculated from three replicate samples. Statistical signiﬁcance was
determined with a paired Student'st test, with *pb0.02, **pb0.005 and ***pb0.002,
respectively.showed hyper-phosphorylation of αB-crystallin, which surprisingly
decreases upon TNF-α treatment (Fig. 6B).3.7. Phosphorylation of αB-crystallin at Ser-59 residue enhances NF-κB
activity
Since our results show increase in the Ser-59 phosphorylation of
αB-crystallin upon TNF-α treatment, we have investigated the
importance of Ser-59 phosphorylated αB-crystallin on the activation
of NF-κB using luciferase reporter assay (Fig. 7A). We ﬁnd that upon
inhibiting αB-crystallin phosphorylation at Ser-59 residue using p38-
MAP kinase inhibitor (SB202190) the activation of NF-κB is reduced in
both C2C12 as well as in CRYAB-C2C12 cells, suggesting that Ser-59
phosphorylation is critical for its activation (Fig. 7A). Interestingly, in
R120G-C2C12 cells, there is no appreciable change in NF-κB activity.
It is possible that the p38-MAP kinase inhibitor, SB202190, though
selective, might have some unintended inhibitory effects on other
kinases as well. To rule out this possibility, we have transiently
transfected C2C12 cells with either the vector alone or the HA-
3A-αBcrystallinmutant followedby TNF-α treatment. Immunolocaliza-
tion and confocal microscopic analyses (Fig. 7B) show that upon TNF-α
treatment, the translocation of p65 is severely affected in HA-
3A-αBcrystallin expressing cells (shown by star) as compared to
parental cells (shown by arrow). We ﬁnd that in the absence of
TNF-α, the nuclear to cytoplasmic mean intensity ratio of p65 is 0.57 in
both parental as well as HA-3A-αBcrystallin transfected cells, suggest-
ing that transfection per se does not affect the cellular localization of
p65. It is noteworthy that after TNF-α treatment, the nuclear to
cytoplasmic ratio of p65 in untransfected cells is increased to 1.12,
whereas it remained practically unchanged (0.62) in cells transfected
with HA-3A-αBcrystallin mutant. Thus our analysis shows that
phosphorylation of αB-crystallin plays an important role in the nuclear
translocation of p65.Fig. 10. αB-crystallin induced NF-κB activity enhances the expression of anti apoptotic
protein, Bcl 2. A. Western blots showing the level of Bcl 2 expression [top panel] and
actin [bottom panel] in untreated and TNF-α-treated C2C12, CRYAB-C2C12 and R120G-
C2C12 cells. B. The fold change in the expression of Bcl 2 levels of untreated and TNF-α-
treated C2C12, CRYAB-C2C12 and R120G-C2C12 cells respectively is represented in the
bar diagram [bottom panel]. Statistical signiﬁcance was determined with a paired
Student'st test, with **pb0.005.
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activation but not for the interaction with IKK complex
In order to investigate whether Ser-59 phosphorylation of αB-
crystallin inﬂuences the interaction and activation of IKK complex, we
have treated C2C12 and CRYAB-C2C12 cells with p38-MAP kinase
inhibitor (SB202190) followed by TNF-α treatment. Cell lysates were
immunoprecipitated with antibodies speciﬁc to αB-crystallin and
immunoblotted with antibodies speciﬁc to IKKβ or αB-crystallin. We
didnot observe signiﬁcantdifference in interaction ofαB-crystallinwith
the IKK complex evenwhen cells were treatedwith SB202190 (Fig. 8A).
This suggests that the association between αB-crystallin and IKK
complex is not dependent on the phosphorylation of αB-crystallin. To
investigate whether Ser-59 phosphorylation of αB-crystallin has any
inﬂuence on IKK kinase activity, we performed the kinase activity of the
immunoprecipitates obtained from cell lysates described above. We
observed a signiﬁcant decrease in the kinase activity in both the normal
C2C12 and CRYAB-C2C12 cells treated with SB202190 (Fig. 8B). Taken
together, our data show that Ser-59 phosphorylation of αB-crystallin is
not essential for its association with the IKK complex, but appears to be
important for the enhancement of its kinase activity.Fig. 11. Schematic representation of the role of αB-crystallin in the activation of NF-κB path
involving p38-MAP kinase pathway. The left side of the ﬁgure depicts the results of the
αB-crystallin associates with and enhances the kinase activity of IKK complex, thereby facilit
nuclear translocation and transcriptional activation by NF-κB-p65-protein. The elevated exp
protection to cells against TNF-α-induced cytotoxicity. The ﬁgure also depicts the cytoprote
and activation of caspase-3 and (b) prevention of the mitochondrial translocation of pro-ap3.9. Enhanced activation of NF-κB leads to increased protection in cells
over-expressing αB-crystallin
NF-κB is known to be involved in processes that lead to pro-
apoptotic or anti-apoptotic cellular responses [39,50]. To ﬁnd out the
effect of αB-crystallin induced NF-κB activation, C2C12, CRYAB-C2C12
and R120G-C2C12 cells were ﬁxed in 80% ethanol, stained with
propidium iodide (PI) and analyzed by ﬂuorescence activated cell
sorter (FACS). FACS analysis showed that ~5% of the normal untreated
C2C12 cells underwent cell death (Fig. 9A). The extent of cell death was
not signiﬁcantly different in CRYAB-C2C12 cells, whereas it was higher
in R120G-C2C12 cells. Upon treatment of C2C12 cells with TNF-α, there
was a signiﬁcant increase in cell death (~65%). Interestingly, CRYAB-
C2C12 cells showed almost no increase in cell death upon similar
treatment. This suggests that over-expression of αB-crystallin contrib-
utes signiﬁcantly in its protectionof cells to TNF-α-induced cell death. In
the case of R120G-C2C12 cells, TNF-α treatment leads to increase in cell
death, which is approximately 42% (Fig. 9A). Interestingly, when the
cells were treated p38-MAP kinase inhibitor, SB202190, and subse-
quently with TNF-α, there was signiﬁcant increase in cell death in
C2C12, CRYAB-C2C12 and R120G-C2C12 cells suggesting loss ofway and in cytoprotection. TNF-α enhances phosphorylation of Ser-59 of αB-crystallin
present investigation on the cytoprotective effects of αB-crystallin. Phosphorylated
ating phosphorylation and subsequent degradation of IκB, a critical step involved in the
ression of Bcl 2, an anti-apoptotic protein and a known target of NF-κB pathway, confers
ctive mechanisms of αB-crystallin reported earlier, viz. (a) inhibition of the maturation
optotic molecules like Bax and Bcl Xs.
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that αB-crystallin enhances the NF-κB activity and prevents TNF-α-
induced cell death in a phosphorylation-dependent manner.
To further elucidate the downstream functions of NF-κB, we
performed Western blot for Bcl 2, a key anti-apoptotic protein, which
is a known target of NF-κB [46,47]. Our Western blot analysis shows
that there is increased expression of Bcl 2 protein in CRYAB-C2C12
cells, whereas in C2C12 or R120G-C2C12 cells, the increase is marginal
(Fig. 10A, B). This suggests that by activation of NF-κB, αB-crystallin
modulates the cell death pathway, thus preventing TNF-α induced
cell death.
4. Discussion
Small HSPs are constitutively expressed in several tissues including
skeletal muscles, where they confer stress tolerance [10,11]. Skeletal
muscles are constantly subjected to injury or stress and require repair
and regeneration to maintain tissue homeostasis. Transgenic mice
lacking the expression of αB-crystallin suffered severe muscle wastage
and premature death [27]. Interestingly, mice knocked out for TNF-α or
its receptor associated factor- TRAF2 result in animals with smaller
musclemass [32]. During conditions of stress, growth factor deprivation
and muscle differentiation, expression of both TNF-α, as well as the
small heat shockprotein,αB-crystallin, has been reported to be elevated
[18,33]. It is also documented that prolonged exposure to high
concentrations of TNF-α induces cell death [41]. However, the role of
αB-crystallin in TNF-α signaling, if any, is not known. TNF-α is a known
activator of NF-κB, a ubiquitously expressed transcription factor, whose
target genes regulate division and death in several cell types.
To investigate the role of αB-crystallin in the activation of NF-κB
pathway, we have used two approaches (i) induced expression of
either αB-crystallin or its functionally compromised mutant-
R120GαB-crystallin or (ii) RNAi-mediated reduction in the levels of
αB-crystallin. Our investigations have revealed that increased
expression of wild type αB-crystallin enhances NF-κB activity. On
the other hand, increased expression of dominant negative mutant-
R120GαB-crystallin or RNAi-mediated reduction of αB-crystallin
negatively modulates NF-κB activity. The underlying mechanism in
this process of NF-κB regulation is schematically presented in Fig. 11.
Upon TNF-α treatment, αB-crystallin associates with IKKβ and
enhances its kinase activity, which leads to phosphorylation and
subsequent degradation of IκB-α, a negative regulator of NF-κB
activity. Degradation of IκBα facilitates nuclear translocation and
enhances the transcription of Bcl 2, a known target of NF-κB. Bcl 2 is an
anti-apoptotic protein and hence protects the cells from TNF-α
induced cytotoxicity.
Phosphorylation of αB-crystallin at Ser-59 residue appears to be
essential in the activation NF-κB. TNF-α has earlier been shown to
activate p38-MAP kinase [44]. The p38 MAP kinase is known to
phosphorylate αB-crystallin at Ser-59 residue [49]. Though Ser-59
phosphorylation is not required for association of αB-crystallin with
the IKK complex, it is essential for enhancing the kinase activity of IKβ.
Hsp 27, another closely related member of the small heat shock
protein family, has also been shown to negatively or positively
regulate NF-κB activity. It associates with IKKβ and negatively
regulates NF-κB activity [51,52], or facilitates IκB-α degradation,
thereby enhancing NF-κB activity [53]. These observations suggest
that though both αB-crystallin and Hsp 27 share sequence homology
and belong to the small heat shock protein family, they function in
different ways in the regulation of NF-κB activity.
NF-κB regulates the expression of genes involved in diverse
biological events such as growth, differentiation and cell death
[37–40]. We observed that activation of NF-κB by αB-crystallin
actually enhances the expression level of the anti-apoptotic protein,
Bcl 2. This is the ﬁrst report to demonstrate the activation of NF-κB by
αB-crystallin, which in turn enhances the expression levels of Bcl 2and confers cytoprotection. Fig. 11 also schematically depicts the
other reported mechanisms by which αB-crystallin inhibits apoptosis
in cells. Importantly, it prevents caspase 3 maturation and activity,
thereby inhibiting apoptosis; it also protects mitochondrial integrity
by preventing the translocation of Bax and Bcl Xs to the mitochondria
[30]. A careful scrutiny of mechanisms reported earlier by which
αB-crystallin prevents cell death reveals inhibition of pro-apoptotic
molecules such as caspase 9, caspase 3 as a key event in this process. In
addition to these mechanisms, we propose yet another mechanism by
which αB-crystallin indirectly elevates the levels of anti-apoptotic
proteins and thereby prevents cell death.
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